Read More Healthcare Industry News ANGLE plc signs deal with AstraZeneca to develop Parsortix-based AR detection assay for prostate cancer studies In a deal valued at £550,000, ANGLE plc (AIM:AGL, OTCQX:ANPCY), a leading liquid biopsy company specializing in circulating… byPallavi MadhirajuMay 4, 2024